Ondot Tablet contains Ondansetron 4mg, a selective 5-HT3 receptor antagonist used primarily for the prevention and treatment of nausea and vomiting associated with chemotherapy, radiotherapy, and postoperative recovery. Ondansetron works by blocking the action of serotonin, a natural substance that may cause nausea and vomiting, at the 5-HT3 receptors located centrally in the chemoreceptor trigger zone and peripherally in the gastrointestinal tract. This mechanism effectively reduces the incidence and severity of emesis. Ondot Tablet is indicated for adult and pediatric patients undergoing emetogenic cancer treatments, as well as for those experiencing postoperative nausea and vomiting. The recommended dosage varies depending on the clinical scenario and patient age, and it should be administered as directed by a healthcare professional. Ondot is generally well tolerated, with common adverse effects including headache, constipation, and dizziness. Caution is advised in patients with hepatic impairment, and it should be used with care in individuals with known hypersensitivity to ondansetron or other 5-HT3 antagonists. Ondot Tablet provides an effective therapeutic option for managing nausea and vomiting, improving patient comfort and compliance during medical treatments.